For pricing in CAD please contact us.

FLAC6 Reagent

FLAC6 Reagent

Regular price
$220.69 USD
Regular price
Sale price
$220.69 USD
Unit price
Sold out

CALIXAR’s FLAC6 reagent is a non-ionic amphiphilic detergent / surfactant with a lactobionamide head group and a fluorinated chain.

(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononylamine) lactobionamide

Compound name: FLAC6

Catalogue number: FLAC6_50MG,FLAC6_100MG,FLAC6_250MG

Molec. Formula: C21H28F13NO11

CAS: nd

MW: 717.4 g/mol

pKa: na​

Percent Composition: C, 35.16; H, 3.93; F, 34.43; N, 1.95; O, 24.53

Physical state: White powder

Purity (HPLC, 214nm): ≥98%

Retention time (RP18 HPLC)b: tR = 13.8 min

CMC: 0.56 mM (TS)

Exact mass​: 717.1455

Stability: Store in <-20°C freezer for up to one year

Solubility Structure: Soluble in water (28mM), methanol and DMSO



CALIXAR uses a unique & custom-produced program 

CALIXAR’s FLAC6 is manufactured into a powder form and is used in an aqueous solution or buffer. FLAC6 can be combined with biological substances (biological membranes).

Clients are able to use FLAC6 to produce lipid detergents, mixed micelles, and protein detergent micelles. FLAC6 empowers clients to extract, to solubilize and to stabilize native and functional membrane proteins in a solution.

FLAC6 is a very gentle non-ionic detergent to extract, solubilize and to stabilize native membrane proteins. As it is indifferent to ionic strength or pH variations it is ideal to extract, solubilize and stabilize particular membrane proteins of high medical relevance.


CALIXAR’s FLAC6 is non-ionic and therefore is not sensitive to ionic strength or pH variations. It is well conformed to extract, to solubilize and to stabilize specific membrane proteins.


CALIXAR’s FLAC6 extracts high-quality membrane proteins used for research, pharmaceutical discovery, and structural studies. FLAC6 is designed for pharmaceutical and biotechnology companies, as-well-as for academic teams (biochemists, structural biologists, pharmacologists, virologists) that are involved in the life science fields.


  • Antibodies (including nanobodies, scaffold proteins, aptamers)
  • Small molecules
  • 3D Structures (cryoEM, XRay crystallography, NMR, SANS, SAXS)
  • Drug discovery (Screening: HTS, FBDD, SBDD; Hit and lead validation)
  • Antibody discovery (Immunization and display technologies)
  • Clinical stage



Lactobionamide Surfactants with Hydrogenated, Perfluorinated or Hemifluorinated Tails

Lebaupain F. et al. 2006